Llansola, M.; Mincheva, G.; Arenas, Y.M.; Izquierdo-Altarejos, P.; Pedrosa, M.A.; Blackburn, T.P.; Bäckström, T.; Scharschmidt, B.F.; Doverskog, M.; Felipo, V.
Golexanolone Attenuates Neuroinflammation, Fatigue, and Cognitive and Motor Impairment in Diverse Neuroinflammatory Disorders. Pharmaceuticals 2025, 18, 1757.
https://doi.org/10.3390/ph18111757
AMA Style
Llansola M, Mincheva G, Arenas YM, Izquierdo-Altarejos P, Pedrosa MA, Blackburn TP, Bäckström T, Scharschmidt BF, Doverskog M, Felipo V.
Golexanolone Attenuates Neuroinflammation, Fatigue, and Cognitive and Motor Impairment in Diverse Neuroinflammatory Disorders. Pharmaceuticals. 2025; 18(11):1757.
https://doi.org/10.3390/ph18111757
Chicago/Turabian Style
Llansola, Marta, Gergana Mincheva, Yaiza M. Arenas, Paula Izquierdo-Altarejos, Maria A. Pedrosa, Thomas P. Blackburn, Torbjörn Bäckström, Bruce F. Scharschmidt, Magnus Doverskog, and Vicente Felipo.
2025. "Golexanolone Attenuates Neuroinflammation, Fatigue, and Cognitive and Motor Impairment in Diverse Neuroinflammatory Disorders" Pharmaceuticals 18, no. 11: 1757.
https://doi.org/10.3390/ph18111757
APA Style
Llansola, M., Mincheva, G., Arenas, Y. M., Izquierdo-Altarejos, P., Pedrosa, M. A., Blackburn, T. P., Bäckström, T., Scharschmidt, B. F., Doverskog, M., & Felipo, V.
(2025). Golexanolone Attenuates Neuroinflammation, Fatigue, and Cognitive and Motor Impairment in Diverse Neuroinflammatory Disorders. Pharmaceuticals, 18(11), 1757.
https://doi.org/10.3390/ph18111757
